Bilateral multicystic dysplastic kidney is a rare genetic/congenital condition where both kidneys are replaced by fluid-filled sacs and do not work. It is usually found on prenatal ultrasound and affects fetuses and newborns. Babies with bilateral multicystic dysplastic kidney cannot make enough urine, so there is too little amniotic fluid and underdeveloped lungs. The condition is typically not compatible with survival, and many pregnancies end in loss or babies pass away soon after birth despite intensive care. Care focuses on prenatal counseling, planning delivery, and supportive measures, and genetic testing can sometimes clarify why it occurred.
Overview
Bilateral multicystic dysplastic kidneySymptoms
Bilateral multicystic dysplastic kidney is usually found on prenatal ultrasound. Features can include very low amniotic fluid, a large, cyst-filled kidney area, and no fetal bladder filling; after birth, babies may have breathing trouble and minimal urine output.
Outlook and prognosis
For many with bilateral multicystic dysplastic kidney, both kidneys are too underdeveloped to support life, and outcomes are often poor. Newborns may face breathing problems from low amniotic fluid and need intensive support. Care teams focus on comfort-centered planning and family guidance.
Causes and risk factors
Bilateral multicystic dysplastic kidney usually results from disrupted kidney development before birth. Most cases are sporadic; risk is higher with inherited or new gene changes, chromosomal conditions, family history of urinary tract malformations, and maternal diabetes or certain early‑pregnancy medications.
Genetic influences
Genetics play a meaningful role in bilateral multicystic dysplastic kidney, though many cases are not inherited. Variants in kidney‑development genes and chromosomal changes can contribute, sometimes appearing with other organ differences. Genetic counseling and testing can clarify risks for future pregnancies.
Diagnosis
Bilateral multicystic dysplastic kidney is usually seen on prenatal ultrasound as cystic, nonfunctioning kidneys and low amniotic fluid. After birth, diagnosis of bilateral multicystic dysplastic kidney is confirmed with ultrasound; genetic tests may be added if features suggest a syndrome.
Treatment and drugs
Treatment for bilateral multicystic dysplastic kidney focuses on supportive care, close monitoring, and planning for kidney support as needed. Teams often prepare for dialysis soon after birth and consider kidney transplant when a child is ready. Care also manages blood pressure, growth, and infections.
Symptoms
Many families first learn about bilateral multicystic dysplastic kidney during a routine pregnancy scan, when both kidneys look filled with many small cysts and the bladder may be hard to see. Early on, this might look like very low amniotic fluid around the baby, which can raise concern about kidney and lung development. The early features of bilateral multicystic dysplastic kidney often include enlarged cystic kidneys on ultrasound and, after birth, very little urine and breathing trouble. Features can look different from baby to baby, depending on how much kidney tissue is present and how the lungs develop.
Scans may show both kidneys replaced by many fluid-filled sacs and appearing larger than expected. The bladder may not fill during the exam because little or no urine is being made. This pattern is consistent with bilateral multicystic dysplastic kidney but can appear in other conditions too.
Because the baby’s kidneys help make amniotic fluid, very low fluid can be a sign the kidneys aren’t working. Low fluid can limit lung growth and reduce space for movement before birth.
On repeat ultrasounds, the bladder may be very small or not seen at all. This happens when little urine is produced and can be an early feature of bilateral multicystic dysplastic kidney.
After birth, babies may have very few wet diapers or none at all. This points to little or no kidney function and needs urgent evaluation.
How people usually first notice Bilateral multicystic dysplastic kidney?
Many families first learn something is different during a routine pregnancy ultrasound, when one or both kidneys look unusually large and full of fluid-filled spaces (cysts) and the care team mentions “multicystic dysplastic kidney.” After birth, doctors may confirm it with a physical exam and ultrasound if a newborn’s belly seems swollen on one side, or after a prenatal finding needs follow-up. Some babies have no obvious symptoms at first, and the “first signs of bilateral multicystic dysplastic kidney” come from imaging done for another reason or because there’s little or no urine seen in the bladder on scans.
Types of Bilateral multicystic dysplastic kidney
Bilateral multicystic dysplastic kidney (MCDK) is a congenital condition where both kidneys are replaced by many small cysts and don’t form or function as they should. Doctors recognize a few clinical variants that reflect how much kidney tissue is working, whether other urinary tract issues are present, and how early problems appear before birth. Symptoms don’t always look the same for everyone. When people search for types of bilateral multicystic dysplastic kidney, they’re often asking how these variants differ in severity and day-to-day impact.
Severe bilateral MCDK
Both kidneys are almost entirely cystic with little to no working tissue. This often leads to very low amniotic fluid in pregnancy and underdeveloped lungs at birth. Newborns may have breathing difficulty and kidney failure soon after delivery.
Partial-function variant
Some small areas of kidney tissue produce a limited amount of urine. Babies may have more normal amniotic fluid and fewer breathing issues at birth. Over time, reduced kidney function can still lead to high blood pressure and growth concerns.
With urinary tract anomalies
MCDK occurs alongside issues like blockage where the kidney drains or abnormal bladder-ureter connections. These added problems can worsen kidney stress and raise infection risk. Imaging guides whether surgery is needed for drainage or reflux.
Associated syndromic form
MCDK appears as part of a broader genetic syndrome with features outside the kidneys, such as limb, heart, or facial differences. Genetic testing may identify a known gene change and help anticipate other health needs. Care is coordinated across specialties.
Prenatal-detected variant
Changes are first seen on mid-pregnancy ultrasound, sometimes with very low amniotic fluid. Monitoring tracks lung development, growth, and signs of kidney function, guiding delivery planning. Parents receive counseling on expected outcomes and supportive care options.
What genetics can tell you about symptoms
Some genetic changes in HNF1B can lead to both kidneys developing many fluid-filled cysts, smaller size, and poor filtering, sometimes with diabetes or electrolyte issues. Variants in genes like PAX2 or EYA1 may cause kidney malformation plus hearing, eye, or urinary tract differences.
Causes and risk factors
Bilateral multicystic dysplastic kidney begins in the womb when kidney development does not follow the usual pattern.
It may result from an abnormal connection between early kidney tissues or from a blockage in the fetal urinary tract that changes how the kidneys form.
Some risks are written in our DNA, passed down through families.
Gene changes can be inherited or arise for the first time, and a family history of kidney or urinary tract differences increases risk.
Other risk factors for Bilateral multicystic dysplastic kidney include maternal diabetes and certain blood pressure medicines during pregnancy, like ACE inhibitors or ARBs, though many cases have no clear cause.
Environmental and biological risk factors
When a baby is developing, kidneys and the urinary tract form very early in pregnancy. In bilateral multicystic dysplastic kidney, small disruptions during this window can raise the chance the kidneys do not form normally; understanding risk factors for bilateral multicystic dysplastic kidney can help guide conversations before or during pregnancy. That said, biology and environment work hand in hand. The elements below outline biological and environmental factors that may increase likelihood before birth.
Blockage of urine flow in the fetus can interfere with kidney shaping in the first trimester. Pressure and backflow may cause disorganized tissue with many cysts. When both sides are affected, the likelihood of bilateral multicystic dysplastic kidney increases.
If the early connection between the budding ureter and the kidney tissue is mistimed or misplaced, the kidney may not mature properly. This mismatch can result in dysplasia with multiple cysts. Such developmental errors raise the risk of bilateral multicystic dysplastic kidney.
High blood sugar present before pregnancy and in the first weeks of gestation is linked to a higher rate of birth defects, including urinary tract malformations. This biological condition in the mother increases the chance of abnormal kidney development in the baby.
Medicines such as ACE inhibitors, angiotensin receptor blockers (ARBs), or isotretinoin taken in early pregnancy have been associated with kidney malformations. Exposure during organ formation can disrupt signals that guide kidney development. This may raise the risk of severe kidney dysplasia.
Genetic risk factors
Bilateral multicystic dysplastic kidney can occur on its own or as part of broader kidney and urinary tract development differences. The genetic causes of bilateral multicystic dysplastic kidney include single-gene changes, small missing or extra pieces of chromosomes, and, less often, full chromosome conditions. Many families have no identified gene despite testing, while in others a clear inherited pattern is seen. Carrying a genetic change doesn’t guarantee the condition will appear.
HNF1B changes: Changes in the HNF1B gene, or a small missing piece on chromosome 17 that includes it (17q12 deletion), are a recognized cause in kidney development conditions. They can be inherited from a parent or arise for the first time, and the severity varies widely in families. In some, this presents as bilateral multicystic dysplastic kidney.
PAX2 variants: A single changed copy of PAX2 can disrupt kidney formation and sometimes affect eye development. This follows an autosomal dominant pattern, so each child of an affected parent has a chance to inherit the change. Findings can range from mild differences to multicystic dysplasia.
EYA1 or SIX1: Gene changes causing branchio-oto-renal syndrome may include kidney dysplasia along with ear pits or hearing differences. When inherited in an autosomal dominant way, features can differ between relatives. Occasionally, both kidneys are affected.
Ciliopathy syndromes: Autosomal recessive conditions such as Meckel-Gruber (genes like TMEM67 or CEP290) can lead to severe cystic kidney dysplasia. Both parents are typically healthy carriers, and each pregnancy has a higher chance to be affected. Bilateral cystic kidney dysplasia is common in these syndromes.
Chromosome aneuploidies: Some pregnancies with trisomy 13 or trisomy 18 show bilateral multicystic dysplastic kidney on prenatal scans. These involve an extra whole chromosome and are usually linked with multiple other findings.
Copy-number variants: Small missing or extra pieces of DNA outside 17q12 can disturb kidney-forming genes. These changes may be new in the child and not present in either parent. They can contribute to cystic dysplasia.
Family CAKUT history: Having relatives with kidney or urinary tract differences raises the chance of similar findings due to shared genes. In autosomal dominant families, the same gene change can show up as different kidney features across relatives. Some may have only mild changes.
De novo changes: Some babies with bilateral multicystic dysplastic kidney have a gene change that arose for the first time in them. This usually lowers the chance for future siblings to be affected, though rare exceptions exist.
Recessive carrier couples: When both parents carry the same nonworking gene, there is a 1 in 4 (25%) chance in each pregnancy for an affected child. This pattern is typical of several severe syndromes that include bilateral kidney dysplasia.
No gene identified: In a sizable share of cases, current tests do not find a specific genetic cause even when bilateral multicystic dysplastic kidney looks typical. This may reflect limits of today’s tools or many small genetic influences acting together.
Lifestyle risk factors
Daily habits do not cause bilateral multicystic dysplastic kidney, but they can influence symptoms, blood pressure, and complications across dialysis or post-transplant care. The points below focus on how lifestyle affects bilateral multicystic dysplastic kidney by shaping fluid balance, cardiovascular strain, and infection risk. Work with your kidney team to individualize targets for age, growth needs, and treatment stage.
High-salt foods drive fluid retention and hypertension, increasing strain on dysplastic or transplanted kidneys. Targeted sodium restriction can reduce swelling and help control blood pressure, improving dialysis comfort and graft health.
Too much fluid can lead to high blood pressure, shortness of breath, and difficult dialysis sessions; too little risks low blood pressure and cramps. Following individualized fluid limits supports heart function and eases symptoms between treatments.
Before dialysis or transplant, excessive protein can raise uremic toxins and worsen symptoms. On dialysis, adequate high-quality protein supports growth, healing, and infection defense. A renal dietitian can tailor amounts.
Gentle, regular activity helps control blood pressure, maintains bone and muscle, and improves energy in anemia. Sessions timed away from dialysis and transplant recovery restrictions make activity safer and more comfortable.
Risk prevention
True prevention of bilateral multicystic dysplastic kidney isn’t always possible because it develops as the kidneys form early in pregnancy. Care focuses on planning before pregnancy, avoiding known fetal kidney harms, and using prenatal screening to spot concerns early. Different people need different prevention strategies—there’s no single formula. Early signs of bilateral multicystic dysplastic kidney on prenatal ultrasound can sometimes be seen in the second trimester.
If there’s a family history or a known genetic syndrome, meet with a genetics professional before pregnancy. They can explain recurrence risks and options for testing in a future pregnancy. This helps tailor plans to your family.
Before and during pregnancy, review all medicines with your clinician, including over‑the‑counter drugs and supplements. Avoid medications known to harm fetal kidneys, such as ACE inhibitors or ARBs, unless no safe alternative exists.
Keep health issues like high blood pressure or diabetes well controlled before conception and during pregnancy. Good control reduces overall fetal stress and may lower the chance of kidney‑related complications.
Do not use tobacco, alcohol, or illicit drugs during pregnancy, and limit NSAIDs—especially late in pregnancy—unless your clinician advises otherwise. These exposures can affect fetal kidney blood flow and development.
Transmission
Bilateral multicystic dysplastic kidney is not infectious and cannot be passed between people. It develops before birth when the baby’s kidneys do not form in the usual way, so there’s no exposure risk to family members, classmates, or coworkers.
Most cases happen by chance with no family history, though a smaller number are linked to genetic changes or part of a broader genetic syndrome. When there is genetic transmission of bilateral multicystic dysplastic kidney, it may rarely run in families because of a single changed gene from one parent (dominant) or because of paired changes, one from each parent (recessive), and the chance of it happening again depends on the exact cause. If you’ve had a pregnancy affected by bilateral multicystic dysplastic kidney, a genetics professional can explain how bilateral multicystic dysplastic kidney is inherited in your situation and discuss future pregnancy risks.
When to test your genes
Consider genetic testing if bilateral multicystic dysplastic kidney is diagnosed on prenatal ultrasound, if there’s a family history of kidney malformations or early kidney failure, or if other birth differences are present. Testing can guide monitoring, predict risks for siblings, and tailor care. A genetic counselor can help choose the right test.
Diagnosis
Bilateral multicystic dysplastic kidney is most often found before birth during routine pregnancy scans, based on how the kidneys look and how well they seem to work. For some, routine check-ups reveal the first clues. Diagnosis focuses on clear imaging features and confirming that both kidneys lack functioning tissue, while ruling out other conditions that can look similar. In urgent newborn situations, teams move quickly to confirm findings and guide supportive care.
Doctors usually begin with a detailed ultrasound to look for many non‑communicating cysts replacing both kidneys and loss of normal kidney shape. Sonographers also check the rest of the urinary tract and look for other structural differences. These patterns make bilateral disease more apparent than in a single kidney.
Low amniotic fluid after mid‑pregnancy and a persistently small or non‑filling fetal bladder suggest the kidneys are not producing urine. These findings support the diagnosis and signal higher risk for lung underdevelopment. Severity helps guide counseling and delivery planning.
Color Doppler can show absent or very small renal arteries, indicating minimal kidney perfusion. This supports the impression that the kidneys are not functioning. It can also help distinguish severe obstruction from true dysplasia.
MRI may be used when ultrasound views are limited or the diagnosis is uncertain. It provides detailed anatomy and can estimate lung volumes to assess breathing risk after birth. MRI is an add‑on test, not a replacement for ultrasound.
Stages of Bilateral multicystic dysplastic kidney
Bilateral multicystic dysplastic kidney does not have defined progression stages. It’s a congenital finding present before birth, and outcomes depend on how much working kidney tissue is there at delivery rather than a gradual change over time. Early symptoms of bilateral multicystic dysplastic kidney are uncommon because the condition is usually found on prenatal ultrasound rather than by what a newborn feels. Different tests may be suggested to help confirm the finding and assess kidney function, such as ultrasound imaging, blood and urine tests after birth, and sometimes review by a kidney or genetics specialist.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with bilateral multicystic dysplastic kidney (MCDK), the outlook is serious because both kidneys are affected from birth and do not develop working tissue. This often leads to very limited kidney function before or soon after delivery. When kidney function is too low to support basic body needs, newborns can face life-threatening complications such as severe breathing difficulties from low amniotic fluid and metabolic imbalance.
The outlook is not the same for everyone, but most cases of truly bilateral MCDK have a high risk of stillbirth or death shortly after birth. In rare situations where some kidney tissue works or there’s a backup source of filtration, babies may survive the newborn period and will need intensive kidney care. That may include dialysis in infancy, careful fluid and blood pressure management, and planning for a kidney transplant when the child is big enough. Early symptoms of bilateral multicystic dysplastic kidney in pregnancy may include very low amniotic fluid on ultrasound and a small chest size, which can affect lung growth.
Prognosis refers to how a condition tends to change or stabilize over time. For survivors, long-term outcomes depend on how much kidney function can be supported and on avoiding complications like infections, high blood pressure, and poor growth. If dialysis and then transplant are possible, many children can achieve good growth and development, though they will need lifelong follow-up and medicines to protect the transplant. Talk with your doctor about what your personal outlook might look like, including options for delivery planning, neonatal care, and, when appropriate, palliative support.
Long-term effects
Bilateral multicystic dysplastic kidney affects both kidneys before birth, so they do not form working tissue. When neither kidney functions, babies cannot make amniotic fluid, lungs stay small, and life expectancy is usually measured in hours to days after delivery. Long-term effects vary widely, depending on whether any kidney tissue works at all or whether prenatal imaging overcalls the findings. In pregnancy, early signs of bilateral multicystic dysplastic kidney often appear on ultrasound, which helps teams plan care and discuss likely outcomes.
With no working kidney tissue, waste and fluid build up immediately after delivery. This results in end-stage kidney failure from day one. Survival depends on whether any residual function exists.
Too little amniotic fluid prevents the lungs from growing normally. Newborns often cannot breathe effectively, leading to critical respiratory failure.
Little to no fetal urine causes oligohydramnios. This increases pressure in the uterus and limits fetal movement.
Restricted space and fluid can lead to limb contractures and a characteristic facial appearance at birth. These features reflect the tight uterine environment rather than brain or muscle disease.
How is it to live with Bilateral multicystic dysplastic kidney?
Living with bilateral multicystic dysplastic kidney usually means navigating kidney failure early in life, often from birth, with dialysis and ultimately a kidney transplant becoming central parts of daily care. Families organize routines around treatments, medications, growth and nutrition plans, and frequent clinic visits, while watching closely for infections, blood pressure changes, and fluid balance. This can be demanding for parents and caregivers, but with coordinated pediatric nephrology care, social support, and clear plans for school and activities, many children participate in everyday life and families find a steady rhythm. Siblings and caregivers may feel stress and fatigue at times, yet they often become skilled advocates, sharing responsibilities and celebrating milestones big and small.
Treatment and drugs
Treatment for bilateral multicystic dysplastic kidney (MCDK) focuses on supportive care, since both kidneys are affected and cannot function normally. Newborns with bilateral MCDK usually need urgent help with breathing and blood pressure, careful fluid and electrolyte management, and dialysis to do the work of the kidneys; if they stabilize and grow, a kidney transplant is typically the long-term goal. Supportive care can make a real difference in how you feel day to day. Doctors also monitor for complications such as high blood pressure, poor growth, or infections, and treat these promptly; removal of cystic kidney tissue is rarely needed unless it’s causing pressure or infection. Because every child’s situation is unique, your care team will tailor timing of dialysis and transplant based on weight, overall health, and readiness, and will guide families on nutrition, vaccinations, and medicines that protect heart and bone health while awaiting transplant.
Non-drug treatment
Care for bilateral multicystic dysplastic kidney focuses on close monitoring, careful birth planning, and supporting breathing and kidney function right after delivery. Some babies may need kidney replacement therapies, while others benefit most from comfort-focused care, decided together with the care team. Beyond prescriptions, supportive therapies can guide choices for families during pregnancy and after birth. Plans are tailored to each baby’s needs and to what matters most to the family.
Regular ultrasounds track kidney appearance, amniotic fluid, and growth. Doctors also watch the baby’s lungs and overall well-being. Prenatal signs of bilateral multicystic dysplastic kidney are usually first seen on ultrasound.
Maternal–fetal medicine teams help plan timing and place of delivery. They coordinate neonatal and kidney specialists to be ready at birth.
Birth at a center with neonatal intensive care and pediatric kidney services is often recommended. This helps ensure immediate breathing and kidney support if needed.
Newborn teams prepare for possible breathing problems due to low fluid before birth. Support can include oxygen or a ventilator while the baby stabilizes.
Your genes may have an impact on how drugs work for you
Some medicines used in people with bilateral multicystic dysplastic kidney can work differently based on genes that affect drug processing or sensitivity, such as enzymes in the liver or kidney transporters. Pharmacogenetic testing may guide safer dosing and reduce side effects.
Pharmacological treatments
There’s no medicine that can rebuild nonworking kidneys in bilateral multicystic dysplastic kidney. Alongside drug therapy, dialysis and kidney transplant remain important. Most medications for bilateral multicystic dysplastic kidney focus on managing high blood pressure, anemia, bone–mineral balance, acid levels, and infections, or on protecting a kidney transplant. The exact mix depends on your child’s age, kidney function, and whether a transplant has already taken place.
ACE inhibitors like enalapril or lisinopril, and ARBs like losartan, help lower blood pressure and protect remaining kidney tissue. Calcium channel blockers such as amlodipine are added if targets aren’t met. First-line medications are those doctors usually try first, based on safety and how well they work in kids with kidney disease.
If there is some urine output, diuretics like furosemide can reduce swelling and help control blood pressure. Dosing may be increased or lowered gradually to balance fluid status without causing dehydration. Doctors monitor weight, electrolytes, and urine closely.
Erythropoiesis-stimulating agents such as epoetin alfa or darbepoetin alfa help the body make more red blood cells. Iron supplements (oral ferrous sulfate or IV iron sucrose) are often needed so these medicines work well. Blood counts and iron levels guide dose changes.
Calcitriol (active vitamin D) helps balance calcium and parathyroid hormone when kidneys can’t activate vitamin D. Phosphate binders like sevelamer or calcium carbonate lower high phosphate from food to protect bones and blood vessels. Levels of calcium, phosphate, and PTH are checked regularly.
Genetic influences
Genetics can play a role in bilateral multicystic dysplastic kidney, but many cases happen without a known inherited cause. Sometimes the finding is part of a broader genetic syndrome or a new gene change in the baby that wasn’t present in either parent; less often, a parent carries a change and there’s a chance of passing it on. Family history is one of the strongest clues to a genetic influence. Even when a gene change is found, relatives can be affected in different ways—from mild kidney differences to severe bilateral multicystic dysplastic kidney—so results help estimate risk but can’t predict the exact outcome. When a baby is diagnosed, genetic testing for bilateral multicystic dysplastic kidney may be discussed during pregnancy or after birth to look for chromosome or gene changes tied to kidney development. A genetics professional can explain what the results mean for future pregnancies, including recurrence risk and whether parents or siblings might benefit from testing.
Is Bilateral multicystic dysplastic kidney genetic?
Genetics play a meaningful role in bilateral multicystic dysplastic kidney, though many cases are not inherited. Variants in kidney‑development genes and chromosomal changes can contribute, sometimes appearing with other organ differences. Genetic counseling and testing can clarify risks for future pregnancies.
Pharmacogenetics—how genetics influence drug effects
For people living with bilateral multicystic dysplastic kidney, treatment often includes careful management of kidney failure early in life and, for many, planning toward a future transplant. After a kidney transplant, genes can influence how the body processes certain anti-rejection medicines; this is best studied with tacrolimus, where a common liver enzyme gene (CYP3A5) can affect how quickly the drug is cleared and how much is needed. Genetic testing can sometimes identify how your body handles tacrolimus, helping doctors start at a dose that’s more likely to reach the right blood level with fewer adjustments. If azathioprine is part of the plan, testing for TPMT or NUDT15 can guide safer dosing to reduce the chance of severe low white blood cells; many centers now consider genetic testing for tacrolimus dosing after transplant as well. Other medicines used in people with bilateral multicystic dysplastic kidney—such as blood pressure tablets, antibiotics, or pain relievers—are usually adjusted based on kidney function, age, and other prescriptions rather than genetics. Genes are just one part of the picture; weight, other health conditions, and whether someone is on dialysis or has a transplant also shape which drugs are chosen and at what dose.
Interactions with other conditions
When both kidneys are replaced by non-working cysts, other health issues often come into play. Doctors call it a “comorbidity” when two conditions occur together, and with bilateral multicystic dysplastic kidney this often includes very low amniotic fluid before birth, which can limit lung development and lead to serious breathing problems at delivery. Heart or other urinary tract malformations may occur alongside bilateral multicystic dysplastic kidney and can influence how safely a newborn tolerates procedures like dialysis or later transplant planning. Some babies also have underlying genetic syndromes or chromosome differences, so the care team may suggest genetic testing to understand whether other organs could be affected and to guide family planning. Early symptoms of bilateral multicystic dysplastic kidney are usually seen on prenatal ultrasound as markedly reduced amniotic fluid, which also signals a higher risk for complications like underdeveloped lungs. While the condition often causes little to no kidney function at birth, the exact mix of associated problems varies, so coordinated care among neonatal, kidney, heart, and genetics specialists is essential.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with very large bellies and trouble feeding, only later learning the swelling came from enlarged kidneys. In some families, midwives and doctors quietly noted that several babies over the years were born with kidney problems on both sides. These early observations hinted at patterns long before scans could show what was happening inside.
First described in the medical literature as unusually “cystic” kidneys found after birth or during surgery, bilateral multicystic dysplastic kidney was initially understood only through what could be seen or felt. Doctors saw clusters of tiny fluid-filled sacs replacing normal kidney tissue, and they noticed that when both kidneys were affected, babies often had too little amniotic fluid during pregnancy. Over time, descriptions became more precise as prenatal ultrasound spread in the 1970s and 1980s, allowing clinicians to recognize the condition before birth.
With each decade, imaging improved. Ultrasound, and later detailed fetal scans, helped tell apart a kidney that was poorly formed and full of cysts from other causes of enlarged kidneys. This shifted care from surprise findings after delivery to planned monitoring during pregnancy. It also revealed how variable bilateral multicystic dysplastic kidney can be—severe in some pregnancies, and, in rare reports, mixed with other kidney or urinary tract differences.
Advances in genetics added another layer. Researchers learned that while many cases of bilateral multicystic dysplastic kidney occur without a clear inherited cause, some families carry changes in genes that guide kidney development, acting a bit like a dimmer switch turned too low during early growth. These insights helped explain why a few relatives might share kidney or urinary tract differences even if their exact diagnoses are not the same.
In recent decades, awareness has grown that outcomes depend on how much working kidney tissue is present and whether other organs are involved. Historical differences highlight why today’s counseling focuses on individualized assessment rather than a single prediction. Prenatal teams now combine ultrasound findings, measurements of amniotic fluid, and, when needed, genetic testing to guide discussions with parents about delivery planning and newborn care.
Looking back helps explain current practice: careful prenatal detection, coordinated delivery in centers with neonatal and kidney specialists, and follow-up that watches for breathing issues at birth and kidney function over time. Each stage in history has added to the picture we have today, moving from bedside descriptions to precise imaging and genetics, and shaping how clinicians support families facing bilateral multicystic dysplastic kidney.